Javier Torres
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Javier Torres has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Miguel Lallena
Universidad de Granada
3 shared publications Julio F. Almansa
Servicio de Física y Protección Radiológica, Hospital Regional Universitario Virgen de las Nieves, E-18014 Granada, Spain
2 shared publications- Luis Alberto Pérez Romasanta
Radiation Oncology Service, Salamanca University Hospital, 37007 Salamanca, Spain
2 shared publications Rafael Guerrero
Servicio de Radiofísica y Protección Radiológica, Hospital Universitario San Cecilio, E-18012 Granada, Spain
2 shared publicationsA. Gonzalez-Lopez
1 shared publicationAlberto León
A Neurology , Hospital General Universitario de Ciudad Real , Ciudad Real , Spain
1 shared publication
Latest Publications
- 9 July 2018
- Published by Taylor & Francis in Neurological Research
- Vol. 40 (10) , 900-905
Freezing of gait in Parkinson’s disease: functional neuroimaging studies of the frontal lobe
Objective: The objective of the study is to study a group of patients with Parkinson’s disease (PD) with and without freezing of gait (FOG) and analyze neuropsychological differences, especially regarding executive functions, according to their performance in a set of tests, and potential anomalies in functional positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography (18F-FDG PET/CT) neuroimaging results of the frontal lobe. Methods: The study recruited 23 patients. We performed an 18F-FDG PET/CT scan for 17 patients (9 with FOG and 8 without FOG) and 6 controls. Frontal functions were evaluated in all the patients during their ‘on’ situation. Results: In FDG PET studies, PD patients differed from controls in that they presented hypometabolic areas in the parietal and bilateral occipital regions, as well as in the bilateral frontal region, especially on the right side. Compared to patients without FOG, patients with FOG displayed more pronounced frontal and predominantly right-sided hypometabolism. Both groups of patients displayed a poorer performance than the control population in the frontal cognitive tests. A greater executive disfunction was found in patients with FOG. Conclusions: Our study revealed greater hypometabolism in FDG PET studies, predominantly in right-sided-specific motor regions of the frontal lobe in FOG patients and greater frontal disfunction in neuropsychological tests in PD patients with FOG. These data suggest that FOG may be related to functional impairment of the circuits connecting the frontal lobe and the basal ganglia.
- 9 July 2018
- Published by Taylor & Francis in Neurological Research
- Vol. 40 (10) , 900-905
Freezing of gait in Parkinson’s disease: functional neuroimaging studies of the frontal lobe
Objective: The objective of the study is to study a group of patients with Parkinson’s disease (PD) with and without freezing of gait (FOG) and analyze neuropsychological differences, especially regarding executive functions, according to their performance in a set of tests, and potential anomalies in functional positron emission tomography with 2-deoxy-2-[fluorine-18]fluoro-d-glucose integrated with computed tomography (18F-FDG PET/CT) neuroimaging results of the frontal lobe. Methods: The study recruited 23 patients. We performed an 18F-FDG PET/CT scan for 17 patients (9 with FOG and 8 without FOG) and 6 controls. Frontal functions were evaluated in all the patients during their ‘on’ situation. Results: In FDG PET studies, PD patients differed from controls in that they presented hypometabolic areas in the parietal and bilateral occipital regions, as well as in the bilateral frontal region, especially on the right side. Compared to patients without FOG, patients with FOG displayed more pronounced frontal and predominantly right-sided hypometabolism. Both groups of patients displayed a poorer performance than the control population in the frontal cognitive tests. A greater executive disfunction was found in patients with FOG. Conclusions: Our study revealed greater hypometabolism in FDG PET studies, predominantly in right-sided-specific motor regions of the frontal lobe in FOG patients and greater frontal disfunction in neuropsychological tests in PD patients with FOG. These data suggest that FOG may be related to functional impairment of the circuits connecting the frontal lobe and the basal ganglia.
- 1 September 2017
- Published by Elsevier in Brachytherapy
- Vol. 16 (5) , 1073-1080
Monte Carlo dosimetric characterization of the Flexisource Co-60 high-dose-rate brachytherapy source using PENELOPE
- 1 September 2017
- Published by Elsevier in Brachytherapy
- Vol. 16 (5) , 1073-1080
Monte Carlo dosimetric characterization of the Flexisource Co-60 high-dose-rate brachytherapy source using PENELOPE
- 1 December 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (8) , 960-967
Dosimetric characterization of the 60Co BEBIG Co0.A86 high dose rate brachytherapy source using PENELOPE
- 1 December 2014
- Published by Elsevier in Physica Medica
- Vol. 30 (8) , 960-967
Dosimetric characterization of the 60Co BEBIG Co0.A86 high dose rate brachytherapy source using PENELOPE
- 3 August 2012
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 15 (4) , 283-293
Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes
There are several potential advantages of using 18-fluor-fluorodeoxiglucose (18F-FDG) PET for target volume contouring, but before PET-based gross tumor volumes (GTVs) can reliably and reproducibly be incorporated into high-precision radiotherapy planning, operator-independent segmentation tools have to be developed and validated. The purpose of the present work was to apply the adaptive to the signal/background ratio (RS/B) thresholding method for head and neck tumor delineation, and compare these GTVPET to reference GTVCT volumes in order to assess discrepancies. A cohort of 19 patients (39 lesions) with a histological diagnosis of head and neck cancer who would undergo definitive concurrent radiochemotherapy or radical radiotherapy with intensity-modulated radiotherapy technique (IMRT), were enrolled in this prospective study. Contouring on PET images was accomplished through standardized uptake value (SUV)-threshold definition. The threshold value was adapted to RS/B. To determine the relationship between the threshold and the RS/B, we performed a phantom study. A discrepancy index (DI) between both imaging modalities, overlap fraction (OF) and mismatch fraction (MF) were calculated for each lesion and imaging modality. The median DI value for lymph nodes was 2.67 and 1.76 for primary lesions. The OF values were larger for CT volumes than for PET volumes (p < 0.001), for both types of lesions. The MF values were smaller for CT volumes than for PET volumes (p < 0.001), for both types of lesions. The GTVPET coverage (OFPET) was strongly correlated with the lesion volume (GTVCT) for metastatic lymph nodes (Pearson correlation = 0.665; p < 0.01). For smaller lesions, despite the GTV volumes were relatively larger on PET than in CT contours, the coverage was poorer. Accordingly, the MFPET/CT was negatively correlated with the lesion volume for metastatic lymph nodes. The present study highlights the considerable challenges involved in using FDG PET imaging for the delineation of GTV in head and neck neoplasms. The methods that rely mainly on SUVmax for thresholding, as the RS/B method, are very sensitive to partial volume effects and may provide unreliable results when applied on small lesions.
- 3 August 2012
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 15 (4) , 283-293
Tumor volume delineation in head and neck cancer with 18-fluor-fluorodeoxiglucose positron emission tomography: adaptive thresholding method applied to primary tumors and metastatic lymph nodes
There are several potential advantages of using 18-fluor-fluorodeoxiglucose (18F-FDG) PET for target volume contouring, but before PET-based gross tumor volumes (GTVs) can reliably and reproducibly be incorporated into high-precision radiotherapy planning, operator-independent segmentation tools have to be developed and validated. The purpose of the present work was to apply the adaptive to the signal/background ratio (RS/B) thresholding method for head and neck tumor delineation, and compare these GTVPET to reference GTVCT volumes in order to assess discrepancies. A cohort of 19 patients (39 lesions) with a histological diagnosis of head and neck cancer who would undergo definitive concurrent radiochemotherapy or radical radiotherapy with intensity-modulated radiotherapy technique (IMRT), were enrolled in this prospective study. Contouring on PET images was accomplished through standardized uptake value (SUV)-threshold definition. The threshold value was adapted to RS/B. To determine the relationship between the threshold and the RS/B, we performed a phantom study. A discrepancy index (DI) between both imaging modalities, overlap fraction (OF) and mismatch fraction (MF) were calculated for each lesion and imaging modality. The median DI value for lymph nodes was 2.67 and 1.76 for primary lesions. The OF values were larger for CT volumes than for PET volumes (p < 0.001), for both types of lesions. The MF values were smaller for CT volumes than for PET volumes (p < 0.001), for both types of lesions. The GTVPET coverage (OFPET) was strongly correlated with the lesion volume (GTVCT) for metastatic lymph nodes (Pearson correlation = 0.665; p < 0.01). For smaller lesions, despite the GTV volumes were relatively larger on PET than in CT contours, the coverage was poorer. Accordingly, the MFPET/CT was negatively correlated with the lesion volume for metastatic lymph nodes. The present study highlights the considerable challenges involved in using FDG PET imaging for the delineation of GTV in head and neck neoplasms. The methods that rely mainly on SUVmax for thresholding, as the RS/B method, are very sensitive to partial volume effects and may provide unreliable results when applied on small lesions.
- 26 January 2011
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 13 (1) , 34-42
Correction of systematic set-up error in breast and head and neck irradiation through a no-action level (NAL) protocol
To quantify systematic and random patient set-up errors in breast and head and neck conventional irradiation and to evaluate a no-action level (NAL) protocol for systematic set-up error off-line correction in head and neck cancer and breast cancer patients. Verification electronic portal images of orthogonal set-up fields were obtained daily for the initial four consecutive fractions for 20 patients treated for breast cancer and for 20 head and neck cancer patients. The calculated systematic error was used to shift the isocentre accordingly on the fifth treatment day. From then until the end of the treatment course, pair orthogonal portal images of set-up fields were obtained weekly. To assess the impact of the protocol, pre- and post-correction systematic errors were compared and PTV margins were estimated before and after correction using published margin recipes. Population systematic set-up error decreased in the breast cancer patient group after the implementation of NAL protocol from 4.0 to 1.7 mm on the x-axis, from 4.7 to 2.1 mm on the y-axis and from 2.8 to 0.9 mm on the zaxis. The percentage of patients with individual systematic set-up error reduction was 80%, 90% and 80% on the x-, y- and z-axes respectively. Population systematic set-up error decreased also in the head and neck cancer patient group from 2.3 to 1.1 mm on the x-axis, from 1.6 to 1.4 mm on the y-axis and from 1.7 to 0.7 mm on the z-axis. The percentage of patients with individual systematic set-up error reduction was 70%, 65% and 85% on the x-, y- and z-axes respectively. Margin reduction achievable with NAL protocol implementation on the x-, y- and z-axes was 6.3, 7.2 and 4.8 mm for breast cancer patients and 3.3, 0.6 and 2.8 mm for head and neck cancer patients. NAL off-line protocol is useful for systematic set-up error correction and PTV margin reduction in conventional breast and head and neck irradiation.
- 26 January 2011
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 13 (1) , 34-42
Correction of systematic set-up error in breast and head and neck irradiation through a no-action level (NAL) protocol
To quantify systematic and random patient set-up errors in breast and head and neck conventional irradiation and to evaluate a no-action level (NAL) protocol for systematic set-up error off-line correction in head and neck cancer and breast cancer patients. Verification electronic portal images of orthogonal set-up fields were obtained daily for the initial four consecutive fractions for 20 patients treated for breast cancer and for 20 head and neck cancer patients. The calculated systematic error was used to shift the isocentre accordingly on the fifth treatment day. From then until the end of the treatment course, pair orthogonal portal images of set-up fields were obtained weekly. To assess the impact of the protocol, pre- and post-correction systematic errors were compared and PTV margins were estimated before and after correction using published margin recipes. Population systematic set-up error decreased in the breast cancer patient group after the implementation of NAL protocol from 4.0 to 1.7 mm on the x-axis, from 4.7 to 2.1 mm on the y-axis and from 2.8 to 0.9 mm on the zaxis. The percentage of patients with individual systematic set-up error reduction was 80%, 90% and 80% on the x-, y- and z-axes respectively. Population systematic set-up error decreased also in the head and neck cancer patient group from 2.3 to 1.1 mm on the x-axis, from 1.6 to 1.4 mm on the y-axis and from 1.7 to 0.7 mm on the z-axis. The percentage of patients with individual systematic set-up error reduction was 70%, 65% and 85% on the x-, y- and z-axes respectively. Margin reduction achievable with NAL protocol implementation on the x-, y- and z-axes was 6.3, 7.2 and 4.8 mm for breast cancer patients and 3.3, 0.6 and 2.8 mm for head and neck cancer patients. NAL off-line protocol is useful for systematic set-up error correction and PTV margin reduction in conventional breast and head and neck irradiation.
- 1 September 2009
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 11 (9) , 615-621
CTV to PTV margins for prostate irradiation. Three-dimensional quantitative assessment of interfraction uncertainties using portal imaging and serial CT scans
Purpose To determine the magnitude of setup and organ motion errors from a subset of prostate cancer patients treated with conventional conformal radiotherapy, and to estimate the CTV-PTV margin according to published margin recipes. Methods and materials Twenty prostate cancer patients were treated with external radiotherapy using electronic portal images (EPIs). Weekly treatment EPIs and pelvic CT scans were obtained. These data allowed interfractional analysis of prostate centre of mass motion and setup error. The margins needed to compensate these uncertainties were calculated. Results Tattoo localisation requires a margin of 9–10.5 mm (LR), 15.2–17.8 mm (anterior-posterior (AP)) and 10.6–12.4 mm (superior-inferior (S-I)). Systematic displacements due to prostatic motion, with standard deviations of 2.4 mm (LR), 4.2 mm (AP) and 3.1 mm (S-I) were found to be larger than setup errors (1.8, 3.0 and 1.7 mm respectively). Conclusions Customised PTV margin definition has been possible through in-house measurements of geometrical clinical uncertainties involved in the conventional conformal radiotherapy process. Uncertainty measurements in our department have proved to be larger than those used in common practice. Additional margin reduction procedures are needed in order to accomplish conformal radiotherapy goals.
- 1 September 2009
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 11 (9) , 615-621
CTV to PTV margins for prostate irradiation. Three-dimensional quantitative assessment of interfraction uncertainties using portal imaging and serial CT scans
Purpose To determine the magnitude of setup and organ motion errors from a subset of prostate cancer patients treated with conventional conformal radiotherapy, and to estimate the CTV-PTV margin according to published margin recipes. Methods and materials Twenty prostate cancer patients were treated with external radiotherapy using electronic portal images (EPIs). Weekly treatment EPIs and pelvic CT scans were obtained. These data allowed interfractional analysis of prostate centre of mass motion and setup error. The margins needed to compensate these uncertainties were calculated. Results Tattoo localisation requires a margin of 9–10.5 mm (LR), 15.2–17.8 mm (anterior-posterior (AP)) and 10.6–12.4 mm (superior-inferior (S-I)). Systematic displacements due to prostatic motion, with standard deviations of 2.4 mm (LR), 4.2 mm (AP) and 3.1 mm (S-I) were found to be larger than setup errors (1.8, 3.0 and 1.7 mm respectively). Conclusions Customised PTV margin definition has been possible through in-house measurements of geometrical clinical uncertainties involved in the conventional conformal radiotherapy process. Uncertainty measurements in our department have proved to be larger than those used in common practice. Additional margin reduction procedures are needed in order to accomplish conformal radiotherapy goals.
- 1 September 2005
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 76, S143-S144
312 Noise in radiochromic film dosimetry with a CCD digitizer
- 1 September 2005
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 76, S143-S144
312 Noise in radiochromic film dosimetry with a CCD digitizer
- 23 January 2004
- Published by Wiley in Medical Physics
- Vol. 31 (2) , 296-304
Dosimetry characterization of 32P intravascular brachytherapy source wires using Monte Carlo codesPENELOPEandGEANT4
- 23 January 2004
- Published by Wiley in Medical Physics
- Vol. 31 (2) , 296-304
Dosimetry characterization of 32P intravascular brachytherapy source wires using Monte Carlo codesPENELOPEandGEANT4